-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, W0Jh1iDzS07jMbkz8ZXJrKpPicAmkjkbHPoQziYPwY9qX1u9T5UgO/Hy9R/9MQDM 4srq+J1g2LrQ29uUK8HJBw== 0000920148-96-000011.txt : 19960701 0000920148-96-000011.hdr.sgml : 19960701 ACCESSION NUMBER: 0000920148-96-000011 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 19960627 ITEM INFORMATION: Other events ITEM INFORMATION: Financial statements and exhibits FILED AS OF DATE: 19960628 SROS: NYSE FILER: COMPANY DATA: COMPANY CONFORMED NAME: LABORATORY CORP OF AMERICA HOLDINGS CENTRAL INDEX KEY: 0000920148 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 133757370 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-11353 FILM NUMBER: 96587634 BUSINESS ADDRESS: STREET 1: 358 S MAIN ST CITY: BURLINGTON STATE: NC ZIP: 27215 BUSINESS PHONE: 8002227566 MAIL ADDRESS: STREET 1: NATIONAL HEALTH LABORATORIES HOLDINGS IN STREET 2: 4225 EXECUTIVE SQUARE, SUITE 800 CITY: LAJOLLA STATE: CA ZIP: 92037 FORMER COMPANY: FORMER CONFORMED NAME: NATIONAL HEALTH LABORATORIES HOLDINGS INC DATE OF NAME CHANGE: 19940314 8-K 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 27, 1996 --------------------------------- (Date of earliest event reported) LABORATORY CORPORATION OF AMERICA HOLDINGS ------------------------------------------------------ (Exact name of registrant as specified in its charter) DELAWARE 1-11353 13-3757370 - --------------- ----------- -------------- (State or other (Commission (IRS Employer jurisdiction or File Number) Identification organization) Number) 358 SOUTH MAIN STREET, BURLINGTON, NORTH CAROLINA 27215 -------------------------------------------------------- (Address of principal executive offices) 910-229-1127 ---------------------------------------------------- (Registrant's telephone number, including area code) Item 5. Other Events On June 27, 1996, the Registrant issued a press release dated as of such date announcing that Haywood D. Cochrane, Jr., Executive Vice President, Chief Financial Officer and Treasurer, intends to leave the Company during the third quarter. After almost twenty years in the laboratory industry, he has decided to pursue an entrepreneurial, venture capital-backed opportunity. Mr. Cochrane will continue his current responsibilities until certain projects are completed and a successor is named. The press release is attached as an exhibit hereto and the text thereof is incorporated in its entirety herein by reference. Item 7. Financial Statements, Pro Forma Financial Information and Exhibits (c) Exhibit 20 Press release of the Registrant dated June 27, 1996. SIGNATURES Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. LABORATORY CORPORATION OF AMERICA HOLDINGS ------------------------------------------ (Registrant) By:/s/ Bradford T. Smith --------------------- Executive Vice President, General Counsel and Secretary Date: June 28, 1996 EXHIBIT INDEX Exhibit Number Exhibit - -------- ------- 20 - Press release of the Registrant dated June 27, 1996. EX-20 2 Exhibit 20 ---------- FOR IMMEDIATE RELEASE Contact: Pamela Sherry (910) 584-5171 Ext. 6768 LABORATORY CORPORATION OF AMERICA ANNOUNCES CHIEF FINANCIAL OFFICER WILL STEP DOWN IN THIRD QUARTER BURLINGTON, NC, June 27, 1996 - Laboratory Corporation of America Holdings (NYSE: LH) (LabCorp) reported today that Haywood D. Cochrane, Jr., Executive Vice President, Chief Financial Officer and Treasurer, has announced his intention to leave the Company during the third quarter. After almost twenty years in the laboratory industry, he has decided to pursue an entrepreneurial, venture capital-backed opportunity. Mr. Cochrane will continue his current responsibilities until certain projects are completed and a successor is named. "With Haywood's assistance, LabCorp has made impressive strides since the merger in 1995 between National Health Laboratories Holdings Inc. and Roche Biomedical Laboratories, Inc.," stated Dr. James B. Powell, President and Chief Executive Officer. "We will accept Haywood's resignation with deep regret and wish him well in his new opportunity. Going forward, we will continue to work towards our established goals as we effect an orderly transition." Laboratory Corporation of America Holdings (LabCorp) is a national clinical laboratory organization with estimated annualized revenues of $1.7 billion. The Company operates primary testing facilities nationally, offering more than 1,700 different clinical assays, from routine blood analysis to more sophisticated technologies. LabCorp performs diagnostic tests for physicians, managed care organizations, hospitals, clinics, long-term care facilities, industrial companies and other clinical laboratories. -----END PRIVACY-ENHANCED MESSAGE-----